While high-dose CD271 + stem cell treated mice (MI271H; p = 0.03) revealed a significantly better survival rate than the untreated MI (MIC) group, there was a clear trend towards better survival in the therapy groups MI133H, MI133L, and MI271L compared to the MIC controls ( Figure 1 A).
← all excerpts
Dose-Independent Therapeutic Benefit of Bone Marrow Stem Cell Transplantation after MI in Mice.
1
—
—